Biomarin Pharm Drug Patent Portfolio
Biomarin Pharm's Family Patents
Clinical Trials
Recent Clinical Trials by Biomarin Pharm:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment | BioMarin Pharmaceutical | NA |
ACTIVE NOT RECRUITING
(Sep 1, 2026)
| PHASE2 |
| Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia | BioMarin Pharmaceutical | NA |
ENROLLING BY INVITATION
(Sep 1, 2026)
| PHASE3 |
| Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia | BioMarin Pharmaceutical | NA |
RECRUITING
(Sep 1, 2026)
| PHASE2, PHASE3 |
| A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature | BioMarin Pharmaceutical | NA |
RECRUITING
(May 1, 2026)
| PHASE2 |
| A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia | BioMarin Pharmaceutical | NA |
ACTIVE NOT RECRUITING
(Mar 1, 2026)
| PHASE2 |
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List